Attached files

file filename
EX-3.1 - EX-3.1 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-3_1.htm
EX-3.3 - EX-3.3 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-3_3.htm
EX-10.5 - EX-10.5 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_5.htm
EX-21.1 - EX-21.1 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-21_1.htm
EX-10.9 - EX-10.9 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_9.htm
EX-10.2 - EX-10.2 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_2.htm
EX-10.6 - EX-10.6 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_6.htm
EX-10.7 - EX-10.7 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_7.htm
EX-10.4 - EX-10.4 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_4.htm
EX-10.3 - EX-10.3 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_3.htm
EX-10.8 - EX-10.8 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_8.htm
S-1 - S-1 - SUPERNUS PHARMACEUTICALS, INC.a2201368zs-1.htm
EX-10.1 - EX-10.1 - SUPERNUS PHARMACEUTICALS, INC.a2201368zex-10_1.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 28, 2010, in the Registration Statement (Form S-1) and related Prospectus of Supernus Pharmaceuticals, Inc. for the registration of shares of its common stock.

 

 

/s/ Ernst & Young LLP

 

 

McLean, Virginia

 

December 21, 2010